Innovate UK is to invest up to £10m in a two-phase competition to promote the development of new diagnostic products and services for use in stratified medicine.
This SBRI competition aims to accelerate and/or increase the development and adoption of innovative diagnostic tools in order to offer better targeted treatment to patients within the UK healthcare system. It also aims to demonstrate the benefits of companies working within the UK ‘enabling infrastructure', which is made up of specialist organisations that can help companies understand healthcare needs and design, evaluate and deliver their products and services into the NHS.
Up to £2m is available for phase 1 of the competition and up to a further £8m may be available in a second phase to further develop successful phase 1 projects. The competition is open to all organisations that can demonstrate a route to market for their solution. Successful organisations will attract a 100% funded development contract of up to £150,000 over nine months in phase 1, with the potential to apply for up to £2m over a further three years in phase 2. Scope Innovate UK will support projects that seek to develop tests capable of classifying patients into groups and selecting them for a clinical treatment (or treatments) currently available in the UK. Innovate UK are looking to fund projects that include the following:
In this competition Innovate UK is not funding projects covering: the development of diagnostic tests that do not give rise to patient stratification diagnostic tests for treatments that are still in development biomarker discovery experiments
For more information, please see the Innovate UK SBRI competition for stratified medicine or the full briefing document.